Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes

Cancer and Metastasis Reviews

Volumn 31, Issue 3-4, 2012, Pages 441-454

  Meadows, Gary G ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cancer; Dietary; Epigenetics; Metastasis suppressor; Nutrients; Phytochemicals

Indexed keywords

3 INDOLEMETHANOL; ANETHOLE; BUTYRIC ACID; CARRAGEENAN; CELESTROL; CURCUMIN; DAIDZEIN; FISH OIL; FLAVONE DERIVATIVE; FOLIC ACID; GENISTEIN; GINSENG EXTRACT; GLUCOSINOLATE; GLYCITEIN; ISOLIQUIRITIGENIN; LINOLEIC ACID; LUTEOLIN; LYCOPENE; MICRORNA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHENYLALANINE; PLANT MEDICINAL PRODUCT; POMEGRANATE EXTRACT; SILIBININ; TANNIN; TYROSINE; UNCLASSIFIED DRUG; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; DIET; DNA METHYLATION; EPIGENETICS; HISTONE ACETYLATION; HUMAN; METASTASIS; NONHUMAN; NUTRIENT; OBESITY; PRIORITY JOURNAL; SUPPRESSOR GENE; WEIGHT REDUCTION;

ANIMALS; DIET; DNA METHYLATION; EPIGENESIS, GENETIC; GENES, TUMOR SUPPRESSOR; HISTONES; HUMANS; NEOPLASM METASTASIS; PLANTS, EDIBLE; SIGNAL TRANSDUCTION;

EID: 84867996373     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9369-5     Document Type: Article

References (118)

1. Aravindaram, K.; & Yang, N. S. (2010). Anti-inflammatory plant natural products for cancer therapy. Planta Medica, 76(11), 1103-1117. doi: 10.1055/s-0030-1249859.
2. Niedzwiecki, A.; Roomi, M. W.; Kalinovsky, T.; & Rath, M. (2010). Micronutrient synergya new tool in effective control of metastasis and other key mechanisms of cancer. Cancer and Metastasis Reviews, 29(3), 529-542. doi: 10.1007/s10555-010-9244-1.
3. Chahar, M. K.; Sharma, N.; Dobhal, M. P.; & Joshi, Y. C. (2011). Flavonoids: a versatile source of anticancer drugs. Pharmacognosy Reviews, 5(9), 1-12. doi: 10.4103/0973-7847.79093PRev-5-1.
4. Meeran, S. M.; Ahmed, A.; & Tollefsbol, T. O. (2010). Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clinica Epigenetics, 1(3-4), 101-116. doi: 10.1007/s13148-010-0011-5.
5. Prasad, S.; Phromnoi, K.; Yadav, V. R.; Chaturvedi, M. M.; & Aggarwal, B. B. (2010). Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Medica, 76(11), 1044-1063. doi: 10.1055/s-0030-1250111.
6. Gupta, S. C.; Kim, J. H.; Prasad, S.; & Aggarwal, B. B. (2010). Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer and Metastasis Reviews, 29(3), 405-434. doi: 10.1007/s10555-010-9235-2.
7. Bertola, A.; Deveaux, V.; Bonnafous, S.; Rousseau, D.; Anty, R.; Wakkach, A.; et al. (2009). Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes, 58(1), 125-133. doi: 10.2337/db08-0400.
8. Milagro, F. I.; Campion, J.; Cordero, P.; Goyenechea, E.; Gomez-Uriz, A. M.; Abete, I.; et al. (2011). A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. The FASEB Journal, 25(4), 1378-1389. doi: 10.1096/fj.10-170365.
9. Fernandez-Twinn, D. S.; Ekizoglou, S.; Martin-Gronert, M. S.; Tarry-Adkins, J.; Wayman, A. P.; Warner, M. J.; et al. (2010). Poor early growth and excessive adult calorie intake independently and additively affect mitogenic signaling and increase mammary tumor susceptibility. Carcinogenesis, 31(10), 1873-1881. doi: 10.1093/carcin/bgq095.
10. Duthie, S. J. (2011). Epigenetic modifications and human pathologies: cancer and CVD. Proceedings of the Nutrition Society, 70(1), 47-56. doi: 10.1017/S0029665110003952.
11. Balter, K.; Moller, E.; & Fondell, E. (2012). The effect of dietary guidelines on cancer risk and mortality. Current Opinion in Oncology, 24(1), 90-102. doi: 10.1097/CCO.0b013e32834e053100001622-201201000-00016.
12. Shoushtari, A. N.; Szmulewitz, R. Z.; & Rinker-Schaeffer, C. W. (2011). Metastasis-suppressor genes in clinical practice: lost in translation? Nature Reviews. Clinical Oncology, 8(6), 333-342. doi: 10.1038/nrclinonc.2011. 65.
13. Stafford, L. J.; Vaidya, K. S.; & Welch, D. R. (2008). Metastasis suppressors genes in cancer. The International Journal of Biochemistry & Cell Biology, 40(5), 874-891. doi: 10.1016/j.biocel.2007.12.016.
14. Yi, Y.; Nandana, S.; Case, T.; Nelson, C.; Radmilovic, T.; Matusik, R. J.; et al. (2009). Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer. Molecular Cytogenetics, 2, 18. doi: 10.1186/1755-8166-2-18.
15. Bouwman, F. G.; de Roos, B.; Rubio-Aliaga, I.; Crosley, L. K.; Duthie, S. J.; Mayer, C.; et al. (2011). 2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting. BMC Medical Genomics, 4, 24. doi: 10.1186/1755-8794-4-24.
16. Yang, M. D.; Lai, K. C.; Lai, T. Y.; Hsu, S. C.; Kuo, C. L.; Yu, C. S.; et al. (2010). Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways. Anticancer Research, 30(6), 2135-2143.
17. Ho, C. C.; Lai, K. C.; Hsu, S. C.; Kuo, C. L.; Ma, C. Y.; Lin, M. L.; et al. (2011). Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways. Human and Experimental Toxicology, 30(4), 296-306. doi: 10.1177/0960327110371991.
18. Wong, A. W.; Paulson, Q. X.; Hong, J.; Stubbins, R. E.; Poh, K.; Schrader, E.; et al. (2011). Alcohol promotes breast cancer cell invasion by regulating the Nm23-ITGA5 pathway. Journal of Experimental & Clinical Cancer Research, 30, 75. doi: 10.1186/1756-9966-30-75.
19. Kato, K.; Long, N. K.; Makita, H.; Toida, M.; Yamashita, T.; Hatakeyama, D.; et al. (2008). Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. British Journal of Cancer, 99(4), 647-654. doi: 10.1038/sj.bjc.6604521.
20. Kushiro, K.; & Nunez, N. P. (2012). Ethanol inhibits B16-BL6 melanoma metastasis and cell phenotypes associated with metastasis. In Vivo, 26(1), 47-58.
21. Hickson, J. A.; Huo, D.; Vander Griend, D. J.; Lin, A.; Rinker-Schaeffer, C. W.; & Yamada, S. D. (2006). The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Research, 66(4), 2264-2270. doi: 10.1158/0008-5472.CAN-05-3676.
22. Herner, A.; Sauliunaite, D.; Michalski, C. W.; Erkan, M.; De Oliveira, T.; Abiatari, I.; et al. (2011). Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling. International Journal of Cancer, 129(10), 2349-2359. doi: 10.1002/ijc.25898.
23. Barthomeuf, C. (2007). Inhibition of S1P-induced angiogenesis, metastasis and inflammation by dietary polyphenols. Free Radical Biology & Medicine, 42(2), 312-313. doi: 10.1016/j.freeradbiomed.2006.11.002.
24. Chien, S. T.; Lin, S. S.; Wang, C. K.; Lee, Y. B.; Chen, K. S.; Fong, Y.; et al. (2011). Acacetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38alpha MAPK signaling pathway. Molecular and Cellular Biochemistry, 350(1-2), 135-148. doi: 10.1007/s11010-010-0692-2.
25. Wang, L.; Kuang, L.; Pan, X.; Liu, J.; Wang, Q.; Du, B.; et al. (2010). Isoalvaxanthone inhibits colon cancer cell proliferation, migration and invasion through inactivating Rac1 and AP-1. International Journal of Cancer, 127(5), 1220-1229. doi: 10.1002/ijc.25119.
26. Huang, X.; Chen, S.; Xu, L.; Liu, Y.; Deb, D. K.; Platanias, L. C.; et al. (2005). Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Research, 65(8), 3470-3478. doi: 10.1158/0008-5472.CAN-04-2807.
27. Fu, Y. M.; & Meadows, G. G. (2007). Specific amino acid dependency regulates the cellular behavior of melanoma. Journal of Nutrition, 137(6 Suppl 1), 1591S-1596S. discussion 1597S-1598S.
28. Lamy, V.; Bousserouel, S.; Gosse, F.; Minker, C.; Lobstein, A.; & Raul, F. (2011). Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells. Oncology Reports, 26(1), 109-114. doi: 10.3892/or.2011.1273.
29. Ferguson, H. J.; & Bhalerao, S. (2010). Gallbladder torsion presenting as chest pain. Annals of the Royal College of Surgeons of England, 92(3), W252-W256. doi: 10.1308/147870810X12659688851357.
30. Ho, Y. T.; Yang, J. S.; Li, T. C.; Lin, J. J.; Lin, J. G.; Lai, K. C.; et al. (2009). Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Letters, 279(2), 155-162. doi: 10.1016/j.canlet.2009.01.033.
31. Senthilkumar, K.; Arunkumar, R.; Elumalai, P.; Sharmila, G.; Gunadharini, D. N.; Banudevi, S.; et al. (2011). Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochemistry and Function, 29(2), 87-95. doi: 10.1002/cbf.1725.
32. Park, K. R.; Nam, D.; Yun, H. M.; Lee, S. G.; Jang, H. J.; Sethi, G.; et al. (2011). beta-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Letters, 312(2), 178-188. doi: 10.1016/j.canlet.2011.08.001.
33. Xu, L.; Ding, Y.; Catalona, W. J.; Yang, X. J.; Anderson, W. F.; Jovanovic, B.; et al. (2009). MEK4 function, genistein treatment, and invasion of human prostate cancer cells. Journal of the National Cancer Institute, 101(16), 1141-1155. doi: 10.1093/jnci/djp227.
34. Meadows, G. G.; Zhang, H.; & Ge, X. (2001). Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines. Journal of Nutrition, 131, 3047S-3050S.
35. Meadows, G. G.; Ge, X.; Zhang, H.; Oros, D. R.; & Fu, Y.-M. (2002). Inhibition of invasion and metastasis during specific amino acid restriction associated with metastasis suppressor and other gene changes. In D. R. Welch (Ed.), Cancer metastasisrelated genes (pp. 191-208, Cancer metastasisbiology and treatment, vol. 3). Dordrecht: Kluwer Academic.
36. Abdallah, R. M.; Starkey, J. R.; & Meadows, G. G. (1987). Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors. Journal of the National Cancer Institute, 78, 759-766.
37. Issa, J. P. (2008). Cancer prevention: epigenetics steps up to the plate. Cancer Prevention Research (Philadelphia, Pa.), 1(4), 219-222. doi: 10.1158/1940-6207.CAPR-08-0029.
38. Herceg, Z. (2007). Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis, 22(2), 91-103. doi: 10.1093/mutage/gel068.
39. Szyf, M. (2006). Targeting DNA methylation in cancer. Bulletin du Cancer, 93(9), 961-972.
40. Parasramka, M. A.; Ho, E.; Williams, D. E.; & Dashwood, R. H. (2012). MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Molecular Carcinogenesis, 51(3), 213-230. doi: 10.1002/mc.20822.
41. Khan, S. I.; Aumsuwan, P.; Khan, I. A.; Walker, L. A.; & Dasmahapatra, A. K. (2012). Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. Chemical Research in Toxicology, 25(1), 61-73. doi: 10.1021/tx200378c.
42. Druesne-Pecollo, N.; & Latino-Martel, P. (2011). Modulation of histone acetylation by garlic sulfur compounds. Anti-Cancer Agents in Medicinal Chemistry, 11(3), 254-259.
43. Davis, C. D.; & Ross, S. A. (2007). Dietary components impact histone modifications and cancer risk. Nutrition Reviews, 65(2), 88-94.
44. Chimonidou, M.; Strati, A.; Tzitzira, A.; Sotiropoulou, G.; Malamos, N.; Georgoulias, V.; et al. (2011). DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clinical Chemistry, 57(8), 1169-1177. doi: 10.1373/clinchem.2011.165902.
45. Hartsough, M. T.; Clare, S. E.; Mair, M.; Elkahloun, A. G.; Sgroi, D.; Osborne, C. K.; et al. (2001). Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Research, 61(5), 2320-2327.
46. Li, Q.; & Chen, H. (2011). Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis. Epigenetics, 6(7), 849-852. doi: 10.4161/epi.6.7.16314.
47. Desrochers, T. M.; Shamis, Y.; Alt-Holland, A.; Kudo, Y.; Takata, T.; Wang, G.; et al. (2012). The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics, 7(1), 34-46. doi: 10.4161/epi.7.118546.
48. Cebrian, V.; Fierro, M.; Orenes-Pinero, E.; Grau, L.; Moya, P.; Ecke, T.; et al. (2011). KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients. American Journal of Pathology, 179(2), 540-546. doi: 10.1016/j.ajpath.2011.05. 009.
49. Lou, W.; Krill, D.; Dhir, R.; Becich, M. J.; Dong, J. T.; Frierson, H. F.; Jr.; et al. (1999). Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Research, 59(10), 2329-2331.
50. Shi, J.; Zhang, G.; Yao, D.; Liu, W.; Wang, N.; Ji, M.; et al. (2012). Prognostic significance of aberrant gene methylation in gastric cancer. American Journal of Cancer Research, 2(1), 116-129.
51. Zhang, Z.; Sun, D.; Van do, N.; Tang, A.; Hu, L.; & Huang, G. (2007). Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. International Journal of Cancer, 120(1), 32-38. doi: 10.1002/ijc.22185.
52. Low, J. S.; Tao, Q.; Ng, K. M.; Goh, H. K.; Shu, X. S.; Woo, W. L.; et al. (2011). A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene, 30(16), 1923-1935. doi: 10.1038/onc.2010.576.
53. Kaminskyy, V. O.; Surova, O. V.; Vaculova, A.; & Zhivotovsky, B. (2011). Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. Carcinogenesis, 32(10), 1450-1458. doi: 10.1093/carcin/bgr135.
54. Noske, A.; Denkert, C.; Schober, H.; Sers, C.; Zhumabayeva, B.; Weichert, W.; et al. (2005). Loss of Gelsolin expression in human ovarian carcinomas. European Journal of Cancer, 41(3), 461-469. doi: 10.1016/j.ejca.2004.10.025.
55. Kikuchi, R.; Tsuda, H.; Kanai, Y.; Kasamatsu, T.; Sengoku, K.; Hirohashi, S.; et al. (2007). Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Research, 67(15), 7095-7105. doi: 10.1158/0008-5472.CAN-06-4567.
56. Sasahara, R. M.; Brochado, S. M.; Takahashi, C.; Oh, J.; Maria-Engler, S. S.; Granjeiro, J. M.; et al. (2002). Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detection and Prevention, 26(6), 435-443.
57. Metge, B. J.; Liu, S.; Riker, A. I.; Fodstad, O.; Samant, R. S.; & Shevde, L. A. (2010). Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology, 78(1), 75-86. doi: 10.1159/000292363.
58. Aghdassi, A.; Sendler, M.; Guenther, A.; Mayerle, J.; Behn, C. O.; Heidecke, C. D.; et al. (2012). Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer. Gut, 61(3), 439-448. doi: 10.1136/gutjnl-2011-300060.
59. Kim, H. R.; Han, R. X.; Diao, Y. F.; Park, C. S.; & Jin, D. I. (2011). Epigenetic characterization of the PBEF and TIMP-2 genes in the developing placentae of normal mice. BMB Reports, 44(8), 535-540.
60. Guan, R. J.; Ford, H. L.; Fu, Y.; Li, Y.; Shaw, L. M.; & Pardee, A. B. (2000). Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Research, 60(3), 749-755.
61. Mielnicki, L. M.; Ying, A. M.; Head, K. L.; Asch, H. L.; & Asch, B. B. (1999). Epigenetic regulation of gelsolin expression in human breast cancer cells. Experimental Cell Research, 249(1), 161-176. doi: 10.1006/excr.1999.4461.
62. Qin, W.; Zhu, W.; Shi, H.; Hewett, J. E.; Ruhlen, R. L.; MacDonald, R. S.; et al. (2009). Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutrition and Cancer, 61(2), 238-244. doi: 10.1080/01635580802404196.
63. Nagao, Y.; Hisaoka, M.; Matsuyama, A.; Kanemitsu, S.; Hamada, T.; Fukuyama, T.; et al. (2012). Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Modern Pathology, 25(1), 112-121. doi: 10.1038/modpathol.2011.142.
64. Xu, Y.; Zhao, F.; Wang, Z.; Song, Y.; Luo, Y.; Zhang, X.; et al. (2012). MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene, 31(11), 1398-1407. doi: 10.1038/onc.2011.340.
65. Song, B.; Wang, C.; Liu, J.; Wang, X.; Lv, L.; Wei, L.; et al. (2010). MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. Journal of Experimental & Clinical Cancer Research, 29, 29. doi: 10.1186/1756-9966-29-29.
66. Fabbri, M.; & Calin, G. A. (2010). Epigenetics and miRNAs in human cancer. Advances in Genetics, 70, 87-99. doi: 10.1016/B978-0-12-380866-0.60004- 6.
67. Shah, M. S.; Schwartz, S. L.; Zhao, C.; Davidson, L. A.; Zhou, B.; Lupton, J. R.; et al. (2011). Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet. Physiological Genomics, 43(10), 640-654. doi: 10.1152/physiolgenomics.00213. 2010.
68. Ernst, A.; Campos, B.; Meier, J.; Devens, F.; Liesenberg, F.; Wolter, M.; et al. (2010). De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene, 29(23), 3411-3422. doi: 10.1038/onc.2010.83.
69. Jazbutyte, V.; & Thum, T. (2010). MicroRNA-21: from cancer to cardiovascular disease. Current Drug Targets, 11(8), 926-935.
70. Gabriely, G.; Wurdinger, T.; Kesari, S.; Esau, C. C.; Burchard, J.; Linsley, P. S.; et al. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Molecular and Cellular Biology, 28(17), 5369-5380. doi: 10.1128/MCB.00479-08MCB.00479-08.
71. Grunder, E.; D'Ambrosio, R.; Fiaschetti, G.; Abela, L.; Arcaro, A.; Zuzak, T.; et al. (2011). MicroRNA-21 suppression impedes medulloblastoma cell migration. European Journal of Cancer, 47(16), 2479-2490. doi: 10.1016/j.ejca.2011.06.041.
72. Yang, C. H.; Yue, J.; Pfeffer, S. R.; Handorf, C. R.; & Pfeffer, L. M. (2011). MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. Journal of Biological Chemistry, 286(45), 39172-39178. doi: 10.1074/jbc.M111.285098.
73. Mudduluru, G.; George-William, J. N.; Muppala, S.; Asangani, I. A.; Kumarswamy, R.; Nelson, L. D.; et al. (2011). Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Bioscience Reports, 31(3), 185-197. doi: 10.1042/BSR20100065.
74. Melkamu, T.; Zhang, X.; Tan, J.; Zeng, Y.; & Kassie, F. (2010). Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. Carcinogenesis, 31(2), 252-258. doi: 10.1093/carcin/bgp208.
75. Kushiro, K.; Chu, R. A.; Verma, A.; & Nunez, N. P. (2011). Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal Transition. Cancer Microenvironment. doi: 10.1007/s12307-011-0087-2.
76. Kushiro, K.; & Nunez, N. P. (2011). Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells. Clinical & Experimental Metastasis, 28(8), 877-886. doi: 10.1007/s10585-011-9418-4.
77. Jiang, W. G.; Hiscox, S.; Bryce, R. P.; Horrobin, D. F.; & Mansel, R. E. (1998). The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells. British Journal of Cancer, 77(5), 731-738.
78. Yang, Y. M.; Chen, B. Q.; Zheng, Y. M.; Wang, X. L.; Liu, J. R.; Xue, Y. B.; et al. (2003). The effects of conjugated linoleic acid on the expression of invasiveness and metastasis-associated gene of human gastric carcinoma cell line. Zhonghua Yu Fang Yi Xue Za Zhi, 37(1), 26-28.
79. Mandal, C. C.; Ghosh-Choudhury, T.; Yoneda, T.; Choudhury, G. G.; & Ghosh-Choudhury, N. (2010). Fish oil prevents breast cancer cell metastasis to bone. Biochemical and Biophysical Research Communications, 402(4), 602-607. doi: 10.1016/j.bbrc.2010.10.063.
80. Dimri, M.; Bommi, P. V.; Sahasrabuddhe, A. A.; Khandekar, J. D.; & Dimri, G. P. (2010). Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis, 31(3), 489-495. doi: 10.1093/carcin/bgp305.
81. Joseph, J.; Mudduluru, G.; Antony, S.; Vashistha, S.; Ajitkumar, P.; & Somasundaram, K. (2004). Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene, 23(37), 6304-6315. doi: 10.1038/sj.onc.12078521207852.
82. Butt, A. J.; Hague, A.; & Paraskeva, C. (1997). Butyrate- but not TGFbeta1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase. Cell Death and Differentiation, 4(8), 725-732. doi: 10.1038/sj.cdd.4400293.
83. Palmer, H. G.; Gonzalez-Sancho, J. M.; Espada, J.; Berciano, M. T.; Puig, I.; Baulida, J.; et al. (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. The Journal of Cell Biology, 154(2), 369-387.
84. So, J. Y.; Lee, H. J.; Smolarek, A. K.; Paul, S.; Wang, C. X.; Maehr, H.; et al. (2011). A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Molecular Pharmacology, 79(3), 360-367. doi: 10.1124/mol.110.068403.
85. Liu, H. K.; Wang, Q.; Li, Y.; Sun, W. G.; Liu, J. R.; Yang, Y. M.; et al. (2010). Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells. The Journal of Nutritional Biochemistry, 21(3), 206-213. doi: 10.1016/j.jnutbio.2008.11.004.
86. Hellmann, J.; Rommelspacher, H.; & Wernicke, C. (2009). Long-term ethanol exposure impairs neuronal differentiation of human neuroblastoma cells involving neurotrophin-mediated intracellular signaling and in particular protein kinase C. Alcoholism, Clinical and Experimental Research, 33(3), 538-550. doi: 10.1111/j.1530-0277.2008.00867.x.
87. King, M. L.; & Murphy, L. L. (2007). American ginseng (Panax quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7 cells. Journal of Experimental Therapeutics and Oncology, 6(2), 147-155.
88. Shah, D. C.; Jais, P.; Haissaguerre, M.; Takahashi, A.; & Clementy, J. (1997). Negative lead I P waves during anteroseptal accessory pathway orthodromic reciprocating tachycardia. The American Journal of Cardiology, 80(2), 227-229.
89. Zhou, Q.; Yan, B.; Hu, X.; Li, X. B.; Zhang, J.; & Fang, J. (2009). Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin. Molecular Cancer Therapeutics, 8(6), 1684-1691. doi: 10.1158/1535-7163.MCT-09- 0191.
90. Yang, S. F.; Yang, W. E.; Kuo, W. H.; Chang, H. R.; Chu, S. C.; & Hsieh, Y. S. (2008). Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Archives of Oral Biology, 53(3), 287-294. doi: 10.1016/j.archoralbio.2007.09.001.
91. Kim, J. E.; Kwon, J. Y.; Lee, D. E.; Kang, N. J.; Heo, Y. S.; Lee, K. W.; et al. (2009). MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin. Biochemical Pharmacology, 77(3), 412-421. doi: 10.1016/j.bcp.2008.10.027.
92. Herzog, A.; Kindermann, B.; Doring, F.; Daniel, H.; & Wenzel, U. (2004). Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics, 4(8), 2455-2464. doi: 10.1002/pmic.200300754.
93. Ullmannova, V.; & Popescu, N. C. (2007). Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detection and Prevention, 31(2), 11011-11018. doi: 10.1016/j.cdp.2007.02.005.
94. El Touny, L. H.; & Banerjee, P. P. (2007). Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells. Biochemical and Biophysical Research Communications, 361(1), 169-175. doi: 10.1016/j.bbrc.2007.07.010.
95. Bao, B.; Wang, Z.; Ali, S.; Kong, D.; Li, Y.; Ahmad, A.; et al. (2011). Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Letters, 307(1), 26-36. doi: 10.1016/j.canlet.2011.03.012.
96. Deep, G.; Gangar, S. C.; Agarwal, C.; & Agarwal, R. (2011). Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. Cancer Prevention Research (Philadelphia, Pa.), 4(8), 1222-1232. doi: 10.1158/1940-6207.CAPR-10-0370.
97. Kim, S.; Han, J.; Kim, J. S.; Kim, J. H.; Choe, J. H.; Yang, J. H.; et al. (2011). Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells. Anticancer Research, 31(11), 3767-3773.
98. Chen, P. N.; Hsieh, Y. S.; Chiang, C. L.; Chiou, H. L.; Yang, S. F.; & Chu, S. C. (2006). Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. Journal of Dental Research, 85(3), 220-225.
99. Chu, S. C.; Chiou, H. L.; Chen, P. N.; Yang, S. F.; & Hsieh, Y. S. (2004). Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Molecular Carcinogenesis, 40(3), 143-149. doi: 10.1002/mc.20018.
100. Momeny, M.; Khorramizadeh, M. R.; Ghaffari, S. H.; Yousefi, M.; Yekaninejad, M. S.; Esmaeili, R.; et al. (2008). Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. European Journal of Pharmacology, 591(1-3), 13-20. doi: 10.1016/j.ejphar.2008.06.011.
101. Kwon, G. T.; Cho, H. J.; Chung, W. Y.; Park, K. K.; Moon, A.; & Park, J. H. (2009). Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. The Journal of Nutritional Biochemistry, 20(9), 663-676. doi: 10.1016/j.jnutbio.2008.06.005.
102. Meng, Q.; Qi, M.; Chen, D. Z.; Yuan, R.; Goldberg, I. D.; Rosen, E. M.; et al. (2000). Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. Journal of Molecular Medicine (Berlin), 78(3), 155-165.
103. Huang, C. S.; Shih, M. K.; Chuang, C. H.; & Hu, M. L. (2005). Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. Journal of Nutrition, 135(9), 2119-2123.
104. Choo, E. J.; Rhee, Y. H.; Jeong, S. J.; Lee, H. J.; Kim, H. S.; Ko, H. S.; et al. (2011). Anethole exerts antimetatstaic activity via inhibition of matrix metalloproteinase 2/9 and AKT/mitogen-activated kinase/nuclear factor kappa B signaling pathways. Biological and Pharmaceutical Bulletin, 34(1), 41-46.
105. Farabegoli, F.; Papi, A.; & Orlandi, M. (2011). (-)-Epigallocatechin- 3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Bioscience Reports, 31(2), 99-108. doi: 10.1042/BSR20090143.
106. Hsu, Y. C.; & Liou, Y. M. (2011). The anti-cancer effects of (-)-epigallocatechin-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. Journal of Cellular Physiology, 226(10), 2721-2730. doi: 10.1002/jcp.22623.
107. O'Connell, M. A.; & Rushworth, S. A. (2008). Curcumin: potential for hepatic fibrosis therapy? British Journal of Pharmacology, 153(3), 403-405. doi: 10.1038/sj.bjp.0707580.
108. Ray, S.; Chattopadhyay, N.; Mitra, A.; Siddiqi, M.; & Chatterjee, A. (2003). Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. Journal of Environmental Pathology, Toxicology and Oncology, 22(1), 49-58.
109. Yan, C.; Jamaluddin, M. S.; Aggarwal, B.; Myers, J.; & Boyd, D. D. (2005). Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Molecular Cancer Therapeutics, 4(2), 233-241.
110. Lin, H. J.; Su, C. C.; Lu, H. F.; Yang, J. S.; Hsu, S. C.; Ip, S. W.; et al. (2010). Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2, -9, FAK, Rho A and Rock-1 gene expression. Oncology Reports, 23(3), 665-670.
111. Wang, L.; Alcon, A.; Yuan, H.; Ho, J.; Li, Q. J.; & Martins-Green, M. (2011). Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells. Integrated Biology (Camb), 3(7), 742-754. doi: 10.1039/c0ib00122h.
112. Huijzer, J. C.; McFarland, M.; Niles, R. M.; & Meadows, G. G. (1996). Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants. Journal of Cellular Physiology, 166(3), 487-494. doi:10.1002/(SICI)1097-4652(199603)166:3<487:: AID-JCP3>3.0.CO;2-L.
113. Krahenbuhl, S.; & Reichen, J. (1992). Adaptation of mitochondrial metabolism in liver cirrhosis. Different strategies to maintain a vital function. Scandinavian Journal of Gastroenterology - Supplement, 193, 90-96.
114. Nagothu, K. K.; Jaszewski, R.; Moragoda, L.; Rishi, A. K.; Finkenauer, R.; Tobi, M.; et al. (2003). Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas. Cancer Detection and Prevention, 27(4), 297-304.
115. Wang, J.; Betancourt, A. M.; Mobley, J. A.; & Lamartiniere, C. A. (2011). Proteomic discovery of genistein action in the rat mammary gland. Journal of Proteome Research, 10(4), 1621-1631. doi: 10.1021/pr100974w.
116. Singh, R. P.; Raina, K.; Sharma, G.; & Agarwal, R. (2008). Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice. Clinical Cancer Research, 14(23), 7773-7780. doi: 10.1158/1078-0432.CCR-08-1309.
117. Kim, E. J.; Shin, M.; Park, H.; Hong, J. E.; Shin, H. K.; Kim, J.; et al. (2009). Oral administration of 3,3′-diindolylmethane inhibits lung metastasis of 4 T1 murine mammary carcinoma cells in BALB/c mice. Journal of Nutrition, 139(12), 2373-2379. doi: 10.3945/jn.109.111864.
118. Huang, C. S.; Liao, J. W.; & Hu, M. L. (2008). Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. Journal of Nutrition, 138(3), 538-543.